Teva Secures European Approval of Trisenox® for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia (APL)
This sector offers enticing opportunities for long-term investors.
The good, the bad, and the hairy among U.S. IT services firms.
Inside Clipper Fund's makeover.
Here's what you should know.
Vitaliy N. Katsenelson, CFA, is a portfolio manager/director of research at Investment Management Associates in Denver, Colo. He is the author of “Active Value Investing: Making Money in Range-Bound Markets” (Wiley 2007). To receive Vitaliy’s future articles by email send a blank email to ...
With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.